Abstract:Preeclampsia (PE) is a unique complication of women during pregnancy, which refers to high blood pressure that develops after 20 weeks of pregnancy with proteinuria or without proteinuria but with new onset of any of the following: thrombocytopenia, renal insufficiency, impaired liver function, pulmonary edema, or headache unresponsive to medication. [ 1 , 2 ] Besides, PE can cause headache, dizziness, nausea, vomiting, epigastric discomfort, and other symptoms. PE is the leading cause of maternal morbidity and mortality worldwide with the incidence of 3% to 8%. [ 3 ] Until now, the pathogenesis of PE is not clear. It is believed that the failure of uterine spiral artery recasting causes placental ischemia and hypoxia dysplasia, a variety of placental factors entering the maternal blood leads to systemic inflammatory response and vascular endothelial damage, and finally, PE is developed. [ 4 ] It has also been suggested that placental stiffness increases in patients with PE for the following reasons: The mechanisms for increased placental stiffness in PE may be that trophoblast invasion of the maternal spiral arteries is impaired, resulting in reduced placental perfusion and in a hypoxic placental milieu. Hypoxia arouses collagen and fibrin deposition and fibrosis, which together leads to increased placental stiffness. [ 2 , 5 , 6 ] Postpartum PE patients can return to normal, so the abnormality of the placenta plays a very important role in the occurrence of PE. Therefore, placental monitoring is of great significance to understand fetal growth and development and take effective clinical treatment in a timely manner. [ 7 ] The diagnosis of PE in the past requires the detection of blood pressure, urine protein, and clinical symptoms of the patient, but not all pregnant women can be tested for the above relevant indicators in time, so that they are only found when they have serious complications, which seriously affects the health of the mother and fetus. At present, there are few indicators that can predict PE, and there is a lack of effective predictors in the first trimester. In particular, there is a lack of effective joint predictors. However, noninvasive and inexpensive character of ultrasound examination has enabled the use of ultrasound for very early detection (in the first and the second trimester) of pregnancy-specific diseases, such as gestational diabetes and PE. [ 8–10 ] Women with hypertensive disorders of pregnancy have increased shear wave elastography (SWE) of the placenta compared with the placentas of women with uneventful pregnancies. [ 11 ] Therefore, we aimed to evaluate the tissue stiffness of the placenta and the placental blood perfusion, respectively, to evaluate the predictive value of these 2 parameters for PE, alone or in combination.

Value of 3D Ultrasonographic Assessment of Placental Volume and Perfusion Indices in The First Trimester As Predictors to The Occurrence of Preeclampsia

The Use of Three-Dimensional Power Doppler Ultrasound in Assessment of Placental Blood Flow and Volume and Its Correlation with Severity of Preeclampsia

Umbilical and middle cerebral arteries Doppler velocimetry in early and late onset pre-eclampsia

First-Trimester Placental and Myometrial Blood Perfusion Measured by Three-Dimensional Power Doppler in Preeclampsia

Maternal Mid-Trimester Placental Growth Factor and Uterine Artery Doppler Velocimetry in Evolution of Pre-Eclampsia

Alteration of vascularization in preeclamptic placentas measured by three-dimensional power Doppler ultrasound

An assessment of vascularity and flow intensity of the placenta in normal pregnancy and pre-eclampsia using three-dimensional ultrasound

Detecting Accuracy of Three Dimensional Power Doppler (3DPD) Vascular Indices for Prenatal Diagnosis of Morbidly Adherent Placenta in Patients with Placenta Previa

Serial evaluation of morphological and biophysical placental attributes in women with normal outcome and preeclampsia

Predicting Adverse Pregnancy Outcomes During the Late First Trimester and Early Second Trimester Using the Uterine Artery Doppler

A study of monitoring risk of preeclampsia pregnant women using three-dimensional color power Doppler ultrasound and u-maspin gene of maternal plasma

Assessment of Placental Vascularization in Pre-Eclampsia Pregnancy by Quantitative 3D Power Doppler Ultrasonography

P182 AORTIC VASCULAR BIOMARKERS FOR THE EARLY DETECTION OF PLACENTAL SYNDROMES DURING PREGNANCY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Investigation Into the Predictive Potential of Three-Dimensional Ultrasonographic Placental Volume and Vascular Indices in Gestational Diabetes Mellitus

First trimester Doppler velocimetry of the uterine artery ipsilateral to the placenta improves ability to predict early-onset preeclampsia.

Predictive value of placental real-time shear wave elastography combined with 3-dimensional power Doppler index for preeclampsia

Value of Quantitative Measurement of Placenta with Three-Dimensional Power Doppler Ultrasonography in Pregnant Women with Pregnancy-Induced Hypertension

The role of second trimester uterine artery Doppler in predicting obstetric and neonatal outcomes in abnormal first trimester maternal serum pregnancy‐associated plasma protein‐A and free β‐human chorionic gonadotropin values

First Trimester Maternal Serum Analytes and Second Trimester Uterine Artery Doppler in the Prediction of Preeclampsia and Fetal Growth Restriction.

A longitudinal and cross-sectional study of placental circulation between normal and placental insufficiency pregnancies

Application Value of Two‐Dimensional Ultrasound Combined With Three‐Dimensional Power Doppler in the Prediction of Macrosomia in Early Pregnancy